Female Health Co Company Profile (NASDAQ:FHCO)

About Female Health Co (NASDAQ:FHCO)

Female Health Co logoThe Female Health Company is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men's and women's health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector. For men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout and sexual dysfunction. Women's Health has product candidates for female sexual health, and advanced breast and ovarian cancers. It manufactures, markets and sells the FC2 Female Condom. FC2 provides dual protection against unintended pregnancy and sexually transmitted infections (STIs), including human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS). Its first generation product is the FC1 Female Condom.

Industry, Sector and Symbol:
  • Sector: Consumer Staples
  • Industry: Personal Products
  • Sub-Industry: Personal Products
  • Symbol: NASDAQ:FHCO
  • CUSIP: 31446210
  • Web: www.femalehealth.com
Capitalization:
  • Market Cap: $38.55 million
  • Outstanding Shares: 31,338,000
Average Prices:
  • 50 Day Moving Avg: $1.02
  • 200 Day Moving Avg: $1.03
  • 52 Week Range: $0.72 - $1.65
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 6.15
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $14.77 million
  • Price / Sales: 2.61
  • Book Value: $1.07 per share
  • Price / Book: 1.15
Profitability:
  • EBIDTA: ($1,220,000.00)
  • Net Margins: -14.65%
  • Return on Equity: -7.20%
  • Return on Assets: -5.59%
Debt:
  • Current Ratio: 3.46%
  • Quick Ratio: 2.88%
Misc:
  • Average Volume: 87,897 shs.
  • Beta: 1.27
  • Short Ratio: 3.05
 

Frequently Asked Questions for Female Health Co (NASDAQ:FHCO)

What is Female Health Co's stock symbol?

Female Health Co trades on the NASDAQ under the ticker symbol "FHCO."

How were Female Health Co's earnings last quarter?

Female Health Co (NASDAQ:FHCO) announced its earnings results on Tuesday, May, 9th. The company reported ($0.06) EPS for the quarter. The firm had revenue of $2.41 million for the quarter. Female Health Co had a negative net margin of 14.65% and a negative return on equity of 7.20%. View Female Health Co's Earnings History.

Who are some of Female Health Co's key competitors?

Who are Female Health Co's key executives?

Female Health Co's management team includes the folowing people:

  • Elgar Peerschke, Chairman of the Board
  • Mitchell S. Steiner M.D., President, Chief Executive Officer, Director
  • Overton B. Parrish Jr., Vice Chairman of the Board
  • Daniel Haines, Chief Financial Officer, Chief Operating Officer
  • Mario Eisenberger, Director
  • Harry Fisch M.D., Director
  • Lucy Lu M.D., Director
  • Georges Makhoul, Director
  • David R. Bethune, Independent Director

Who owns Female Health Co stock?

Female Health Co's stock is owned by a number of of retail and institutional investors. Top institutional investors include OPLER TIMOTHY (5.30%). Company insiders that own Female Health Co stock include Andrew S Love Jr, Andrew S Love, Jr, Daniel Haines, David R Bethune, Georges Makhoul, Harry Fisch, Lucy Lu, Michele Greco, O B Parrish and William R Gargiulo Jr. View Institutional Ownership Trends for Female Health Co.

How do I buy Female Health Co stock?

Shares of Female Health Co can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Female Health Co's stock price today?

One share of Female Health Co stock can currently be purchased for approximately $1.23.


MarketBeat Community Rating for Female Health Co (NASDAQ FHCO)
Community Ranking:  1.2 out of 5 ()
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  9 (Vote Underperform)
Total Votes:  12
MarketBeat's community ratings are surveys of what our community members think about Female Health Co and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Female Health Co (NASDAQ:FHCO) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Female Health Co (NASDAQ:FHCO)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Female Health Co (NASDAQ:FHCO)
Earnings by Quarter for Female Health Co (NASDAQ:FHCO)
Earnings History by Quarter for Female Health Co (NASDAQ:FHCO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017Q2 2017($0.06)$2.41 millionViewListenView Earnings Details
12/12/2016Q4 2016($0.06)$3.56 millionViewN/AView Earnings Details
7/28/2016Q3$0.02$5.56 millionViewListenView Earnings Details
2/2/2016Q1$0.05$6.66 million$8.23 millionViewN/AView Earnings Details
12/1/2015Q4$0.02$7.16 millionViewN/AView Earnings Details
7/30/2015Q315$0.04$7.28 million$7.81 millionViewListenView Earnings Details
4/30/2015Q215$0.07$0.06$9.48 million$11.00 millionViewN/AView Earnings Details
2/3/2015Q115$0.07$0.03$9.91 million$6.66 millionViewN/AView Earnings Details
12/2/2014Q314$0.02($0.02)$5.55 millionViewN/AView Earnings Details
7/31/2014Q214$0.05$0.04$7.28 million$7.90 millionViewN/AView Earnings Details
5/1/2014Q2 2014$0.02$0.01$4.35 millionViewN/AView Earnings Details
2/3/2014Q114$0.05$0.05$9.91 million$6.69 millionViewN/AView Earnings Details
12/3/2013Q4$0.14$0.23$9.90 million$4.80 millionViewListenView Earnings Details
5/2/2013Q2 2013$0.12$7.80 million$9.50 millionViewN/AView Earnings Details
1/30/2013Q1 2013$0.12$8.60 million$9.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Female Health Co (NASDAQ:FHCO)
Current Year EPS Consensus Estimate: $0.15 EPS
Next Year EPS Consensus Estimate: $0.20 EPS

Dividends

Dividend History by Quarter for Female Health Co (NASDAQ:FHCO)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/25/2014quarterly$0.073.84%4/28/20144/30/20145/7/2014
3/24/2014quarterly$0.074/30/20144/7/2014
12/16/2013quarterly$0.073.56%1/27/20141/29/20142/5/2014
10/4/2013quarterly$0.072.87%10/28/201310/30/201311/6/2013
7/16/2013quarterly$0.072.99%7/29/20137/31/20138/7/2013
3/27/2013quarterly$0.073.87%4/29/20135/1/20135/8/2013
1/3/2013quarterly$0.063.25%1/28/20131/30/20132/6/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Female Health Co (NASDAQ:FHCO)
Insider Ownership Percentage: 9.80%
Institutional Ownership Percentage: 8.96%
Insider Trades by Quarter for Female Health Co (NASDAQ:FHCO)
Insider Trades by Quarter for Female Health Co (NASDAQ:FHCO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/24/2017Harry FischDirectorBuy10,000$1.10$11,000.00View SEC Filing  
5/22/2017Harry FischDirectorBuy24,750$1.02$25,245.00View SEC Filing  
5/17/2017Daniel HainesCFOBuy5,000$1.01$5,050.00View SEC Filing  
5/15/2017Daniel HainesCFOBuy5,000$1.03$5,150.00View SEC Filing  
5/15/2017O B ParrishDirectorBuy20,000$1.02$20,400.00View SEC Filing  
5/12/2017David R BethuneDirectorBuy20,000$1.03$20,600.00View SEC Filing  
5/11/2017Lucy LuDirectorBuy5,000$1.00$5,000.00View SEC Filing  
3/20/2017Georges MakhoulDirectorBuy100,000$1.05$105,000.00View SEC Filing  
2/24/2017Daniel HainesCFOBuy7,931$1.03$8,168.93View SEC Filing  
12/15/2016David R BethuneDirectorBuy200$1.06$212.00View SEC Filing  
8/16/2016Andrew S Love JrDirectorBuy20,214$1.39$28,097.46View SEC Filing  
8/15/2016Andrew S Love JrDirectorBuy4,786$1.32$6,317.52View SEC Filing  
6/10/2016Andrew S Love JrDirectorBuy15,000$1.36$20,400.00View SEC Filing  
6/6/2016Andrew S Love JrDirectorBuy1,210$1.40$1,694.00View SEC Filing  
5/24/2016Michele GrecoCFOBuy4,000$1.28$5,120.00View SEC Filing  
5/24/2016O B ParrishCEOBuy10,000$1.29$12,900.00View SEC Filing  
5/23/2016William R Gargiulo JrDirectorBuy500$1.26$630.00View SEC Filing  
5/20/2016David R BethuneDirectorBuy100$1.26$126.00View SEC Filing  
12/18/2015O B ParrishCEOBuy10,000$1.48$14,800.00View SEC Filing  
12/15/2015Andrew S. Love, Jr.DirectorBuy25,000$1.47$36,750.00View SEC Filing  
2/5/2015Karen Louise KingCEOBuy1,000$3.86$3,860.00View SEC Filing  
8/12/2014O B ParrishDirectorBuy5,000$4.05$20,250.00View SEC Filing  
8/6/2014Donna FelchDirectorBuy2,500$3.90$9,750.00View SEC Filing  
8/4/2014Karen Louise KingCEOBuy2,000$3.94$7,880.00View SEC Filing  
5/13/2014Stephen M DearholtDirectorSell203,936$6.05$1,233,812.80View SEC Filing  
3/18/2014William R Gargiulo JrDirectorBuy1,000$6.81$6,810.00View SEC Filing  
3/17/2014O B ParrishDirectorBuy5,000$6.74$33,700.00View SEC Filing  
12/20/2013Stephen M DearholtDirectorBuy2,000$8.27$16,540.00View SEC Filing  
12/18/2013David R BethuneDirectorBuy4,000$8.07$32,280.00View SEC Filing  
3/8/2013Michele GrecoCFOBuy1,000$7.01$7,010.00View SEC Filing  
9/17/2012Stephen M DearholtDirectorSell25,000$7.02$175,500.00View SEC Filing  
8/9/2012Michael PopeVPSell17,056$5.90$100,630.40View SEC Filing  
8/8/2012Richard E WenningerDirectorSell3,260$6.00$19,560.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Female Health Co (NASDAQ:FHCO)
Latest Headlines for Female Health Co (NASDAQ:FHCO)
Source:
DateHeadline
americanbankingnews.com logoInsider Buying: Female Health Co (FHCO) Director Purchases 10,000 Shares of Stock
www.americanbankingnews.com - May 24 at 8:24 PM
finance.yahoo.com logoVeru Healthcare to Advance Proprietary Drug for the Treatment of Hot Flashes in Men Receiving Prostate Cancer Hormonal Therapy Following FDA Meeting
finance.yahoo.com - May 24 at 12:11 PM
americanbankingnews.com logoFemale Health Co (FHCO) Director Acquires $25,245.00 in Stock
www.americanbankingnews.com - May 22 at 8:14 PM
americanbankingnews.com logoO B. Parrish Purchases 20,000 Shares of Female Health Co (FHCO) Stock
www.americanbankingnews.com - May 16 at 8:44 PM
americanbankingnews.com logoFemale Health Co (FHCO) Director Purchases $20,600.00 in Stock
www.americanbankingnews.com - May 15 at 10:34 PM
finance.yahoo.com logoVeru Healthcare Presents Results from Phase 4 Clinical Study of PREBOOST for Management of Premature Ejaculation
finance.yahoo.com - May 13 at 5:01 PM
finance.yahoo.com logoETFs with exposure to The Female Health Co. : May 12, 2017
finance.yahoo.com - May 12 at 5:46 PM
finance.yahoo.com logoThe Female Health Co. :FHCO-US: Earnings Analysis: Q2, 2017 By the Numbers : May 11, 2017
finance.yahoo.com - May 11 at 5:50 PM
americanbankingnews.com logoFemale Health Co (FHCO) Issues Earnings Results
www.americanbankingnews.com - May 10 at 4:56 PM
finance.yahoo.com logoEdited Transcript of FHCO earnings conference call or presentation 9-May-17 12:00pm GMT
finance.yahoo.com - May 10 at 9:24 AM
finance.yahoo.com logoVeru Healthcare Reports Fiscal 2017 Second-Quarter Financial Results
finance.yahoo.com - May 9 at 9:50 AM
finance.yahoo.com logoInvestor Network: Female Health Company to Host Earnings Call
finance.yahoo.com - May 9 at 9:50 AM
americanbankingnews.com logoFemale Health (FHCO) Earning Positive Press Coverage, Report Finds
www.americanbankingnews.com - May 3 at 3:44 PM
finance.yahoo.com logoThe Female Health Company / Veru Healthcare to Report Fiscal 2017 Second-Quarter Financial Results, Host Conference Call on Tuesday, May 9
finance.yahoo.com - May 2 at 8:08 PM
finance.yahoo.com logoThe Female Health Company / Veru Healthcare Announces Presentation of PREBOOST® Clinical Data at American Urological Association 2017 Annual Meeting
finance.yahoo.com - May 2 at 8:08 PM
americanbankingnews.com logoFemale Health (FHCO) Receiving Positive Press Coverage, Report Shows
www.americanbankingnews.com - April 28 at 12:06 AM
bizjournals.com logoGlobal Female Condom Market - Strategic Assessment and Forecast 2017 - 2022
www.bizjournals.com - April 27 at 5:47 PM
finance.yahoo.com logoThis Biotech Small-Cap Has Big Ambitions
finance.yahoo.com - April 26 at 8:12 PM
americanbankingnews.com logoFemale Health (FHCO) Given Daily Media Impact Score of 0.56
www.americanbankingnews.com - April 20 at 11:50 AM
News IconBRIEF-Female Health Co says new Tamsulosin DRS formulation advances to stage 2
www.businessinsider.com - April 12 at 10:14 PM
finance.yahoo.com logoThe Female Health Company / Veru Healthcare Announces Successful Stage 1 of the Clinical Trial to Evaluate Bioequivalence Between Tamsulosin DRS and FLOMAX®
finance.yahoo.com - April 12 at 10:00 AM
feeds.benzinga.com logoThe Female Health Company / Veru Healthcare Names Robert Getzenberg, Ph.D., as Executive Vice President of Clinical Development
feeds.benzinga.com - April 11 at 9:28 AM
finance.yahoo.com logoETFs with exposure to The Female Health Co. : April 5, 2017
finance.yahoo.com - April 7 at 9:49 AM
americanbankingnews.com logoFemale Health Co (FHCO) Director Purchases $105,000.00 in Stock
www.americanbankingnews.com - March 21 at 7:58 PM
biz.yahoo.com logoFEMALE HEALTH CO Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - March 21 at 5:23 PM
reuters.com logoBRIEF-Female Health Co initiates bioequivalence clinical trial
www.reuters.com - March 9 at 5:41 PM
finance.yahoo.com logoThe Female Health Company / Veru Healthcare Initiates Bioequivalence Clinical Trial Comparing Tamsulosin DRS with FLOMAX®
finance.yahoo.com - March 9 at 5:41 PM
finance.yahoo.com logo8:33 am Female Health initiates Stage 1 of a bioequivalence clinical trial designed to select the optimal formulation of its proprietary Tamsulosin Delayed Release Sachet product
finance.yahoo.com - March 9 at 5:41 PM
finance.yahoo.com logoThe Female Health Company / Veru Healthcare to Host Investor Conference Call on Thursday, March 9th
finance.yahoo.com - March 3 at 5:13 PM
nytimes.com logoRepeal the Health Law?
www.nytimes.com - February 19 at 4:44 PM
businesswire.com logoGlobal Female Condoms Market to Grow at a CAGR of 9.02%, 2017-2021 with The Female Health Company, Cupid, Shanghai Dahua Medical Apparatus & Tianjin CondomBao Dominating ...
www.businesswire.com - February 16 at 10:10 PM
businesswire.com logoGlobal Female Condoms Market to Grow at a CAGR of 9.02%, 2017-2021 with The Female Health Company, Cupid, Shanghai Dahua Medical Apparatus & Tianjin CondomBao Dominating ...
www.businesswire.com - February 16 at 10:10 PM
nasdaq.com logoThe Female Health Company / Veru Healthcare Names Matthew Gosnell, Ph.D., as Senior Vice President
www.nasdaq.com - February 16 at 10:10 PM
nasdaq.com logoThe Female Health Company / Veru Healthcare Names Matthew Gosnell, Ph.D., as Senior Vice President
www.nasdaq.com - February 16 at 10:10 PM
finance.yahoo.com logoThe Female Health Company / Veru Healthcare Names Matthew Gosnell, Ph.D., as Senior Vice President of Manufacturing, Preclinical and Pharmaceutical Development
finance.yahoo.com - February 16 at 5:08 PM
reuters.com logoBRIEF-FEMALE HEALTH COMPANY REPORTS Q1 LOSS PER SHARE $0.04
www.reuters.com - February 11 at 5:16 PM
finance.yahoo.com logoThe Female Health Company / Veru Healthcare Reports Fiscal 2017 First-Quarter Financial Results
finance.yahoo.com - February 9 at 10:50 PM
biz.yahoo.com logoFEMALE HEALTH CO Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - February 9 at 5:48 PM
cnn.com logoFat-shaming could raise health risks, study suggests
www.cnn.com - February 7 at 11:28 PM
bizjournals.com logoRoivant spinoff Myovant moves forward in women’s health
www.bizjournals.com - January 26 at 5:29 AM
forbes.com logo'Ladies Get Paid' Founder Shares How Mental Health Support Can Help Your Career
www.forbes.com - January 17 at 5:55 PM
biz.yahoo.com logoFEMALE HEALTH CO Files SEC form 8-K/A, Financial Statements and Exhibits
biz.yahoo.com - January 17 at 5:55 PM
News IconThe 21 hottest female-founded startups to watch in 2017
www.businessinsider.com - January 8 at 10:18 PM
reuters.com logoBRIEF-Female Health Company launches PREBOOST for premature ejaculation
www.reuters.com - January 6 at 5:45 PM
seekingalpha.com logoFemale Health Co. launches Preboost in U.S.; shares up 3% premarket
seekingalpha.com - January 6 at 5:45 PM
forbes.com logo5 More Assists That Will Help Women Entrepreneurs Score in 2017
www.forbes.com - January 5 at 6:04 PM
cnn.com logoSaudi music video on women's rights goes viral
www.cnn.com - January 5 at 4:23 AM
forbes.com logoHere's What Healthcare For Women In The Workplace Could Look Like In 2017
www.forbes.com - January 3 at 7:26 PM
finance.yahoo.com logoFEMALE HEALTH CO Financials
finance.yahoo.com - December 16 at 5:45 PM
us.rd.yahoo.com logoThe Female Health Company / Veru Healthcare Reports Fiscal 2016 Fourth-Quarter, Full-Year Financial Results
us.rd.yahoo.com - December 13 at 11:16 AM

Social

Chart

Female Health Co (FHCO) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by MarketBeat.com Staff